Yong-Sheng Ke Selected Research

digoxin-like factors

2/2007	[Effect of inhibiting endoxin by antidigoxin antiserum on myocardial ischemia/reperfusion injury in rats].
7/2004	Endoxin antagonist lessens myocardial ischemia reperfusion injury.
6/2004	Endoxin-mediated myocardial ischemia reperfusion injury in rats in vitro.
4/2003	Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Sheng Ke Research Topics

Disease

4	Reperfusion Injury 01/2010 - 06/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2007 - 06/2004
2	Ischemia 02/2007 - 06/2004
1	Infarction (Infarctions) 01/2010
1	Myocardial Reperfusion Injury 01/2010
1	Essential Hypertension 04/2003

Drug/Important Bio-Agent (IBA)

4	digoxin-like factorsIBA 02/2007 - 04/2003
3	Adenosine Triphosphatases (ATPase)IBA 01/2010 - 06/2004
2	Digoxin (Digitek)FDA LinkGeneric 07/2004 - 06/2004
1	Protein Isoforms (Isoforms)IBA 01/2010
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2010
1	Messenger RNA (mRNA)IBA 01/2010
1	Oxygen (Dioxygen)IBA 02/2007
1	Malondialdehyde (Propanedial)IBA 02/2007
1	CalciumIBA 06/2004
1	SodiumIBA 06/2004
1	Valsartan (Vals)FDA Link 04/2003
1	AngiotensinsIBA 04/2003
1	Angiotensin IIIBA 04/2003
1	benazepril (Briem)FDA LinkGeneric 04/2003
1	N 30IBA 04/2003

Therapy/Procedure

1	Combination Drug Therapy (Combination Chemotherapy) 04/2003